570P A first-in-human phase I study of the AXL inhibitor DS-1205c in combination with gefitinib in subjects with EGFR-mutant NSCLC

Saved in:

Bibliographic Details
Published in	Annals of Oncology Vol. 31; p. S488
Main Authors	R. Toyozawa, Isamu Okamoto, G. Takayama, M. Ishigami, M. Uno, K. Goto, Makoto Nishio, E. Slosberg, Masayuki Takeda, Haruyasu Murakami, N. Crawford, T. Jimbo, H. Horinouchi, S. Nakayama, S. Ohwada
Format	Journal Article
Language	Japanese
Published	Elsevier BV 01.09.2020
Online Access	Get full text

Loading…

More Information
ISSN:	0923-7534
DOI:	10.1016/j.annonc.2020.08.684